Bio-Rad Laboratories, Inc. (BIO.B) stock
BIO.BNYSELaboratory Analytical InstrumentsFiscal year ends December 31Also trades as BIO
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026Score 8/3055% above fair value
$379.50+0.00 (0.00%)
Close on Oct 29, 2026Market cap $10.18BP/E 46.2Yield –
Bio-Rad Laboratories price to free cash flow
Price to free cash flow is market cap divided by free cash flow over the trailing twelve months.
Bio-Rad Laboratories's price to free cash flow was 26.9× on Oct 19, 2026, against 23.9× a year earlier. Over the last 5 years it ranged from 17.9× to 174.8×, with a median of 35.3×.
Price to Free Cash Flow at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Oct 19, 2026 | 26.9× | +2.1 |
| 2025 | Dec 31, 2025 | 24.8× | −13.0 |
| 2024 | Dec 31, 2024 | 37.8× | −4.7 |
| 2023 | Dec 29, 2023 | 42.5× | −40.6 |
| 2022 | Dec 30, 2022 | 83.1× | +48.8 |
| 2021 | Dec 31, 2021 | 34.2× | −13.4 |
| 2020 | Dec 31, 2020 | 47.6× | +6.8 |
| 2019 | Dec 31, 2019 | 40.9× | −6.6 |
| 2018 | Dec 31, 2018 | 47.5× | −544.6 |
| 2017 | Jul 31, 2017 | 592.0× | +428.4 |
| 2016 | Dec 30, 2016 | 163.6× | +102.2 |
| 2015 | Dec 31, 2015 | 61.3× | +43.4 |
| 2014 | Dec 31, 2014 | 18.0× | −29.2 |
| 2013 | Dec 31, 2013 | 47.2× | +20.8 |
| 2012 | Dec 31, 2012 | 26.4× | +11.4 |
| 2011 | Dec 30, 2011 | 15.0× | −27.9 |
| 2010 | Dec 31, 2010 | 42.9× | +33.2 |
| 2009 | Dec 31, 2009 | 9.7× | – |